Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BTBD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BAAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00673 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C3orf38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC654841 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLOC1S2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRPD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SOX5P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC134 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS1R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPSECS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MPND - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEFB125 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on